These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 14680815
21. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor. Schmidt JM, Mercure J, Tremblay GB, Pagé M, Kalbakji A, Feher M, Dunn-Dufault R, Peter MG, Redden PR. J Med Chem; 2003 Apr 10; 46(8):1408-18. PubMed ID: 12672240 [Abstract] [Full Text] [Related]
26. Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway. Ishihara Y, Itoh K, Ishida A, Yamazaki T. J Steroid Biochem Mol Biol; 2015 Jan 23; 145():85-93. PubMed ID: 25305410 [Abstract] [Full Text] [Related]
27. Effects of FSH and 17beta-estradiol on the transactivation of estrogen-regulated promoters and cell proliferation in L cells. Pasapera AM, Jiménez-Aguilera Mdel P, Chauchereau A, Milgrom E, Olivares A, Uribe A, Gutiérrez-Sagal R, Ulloa-Aguirre A. J Steroid Biochem Mol Biol; 2005 Mar 23; 94(4):289-302. PubMed ID: 15857748 [Abstract] [Full Text] [Related]
33. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S. J Biol Chem; 2000 May 26; 275(21):15645-51. PubMed ID: 10747867 [Abstract] [Full Text] [Related]
34. Molecular basis of agonism and antagonism in the oestrogen receptor. Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engström O, Ohman L, Greene GL, Gustafsson JA, Carlquist M. Nature; 1997 Oct 16; 389(6652):753-8. PubMed ID: 9338790 [Abstract] [Full Text] [Related]
35. p33(ING1b) stimulates the transcriptional activity of the estrogen receptor alpha via its activation function (AF) 2 domain. Toyama T, Iwase H, Yamashita H, Hara Y, Sugiura H, Zhang Z, Fukai I, Miura Y, Riabowol K, Fujii Y. J Steroid Biochem Mol Biol; 2003 Oct 16; 87(1):57-63. PubMed ID: 14630091 [Abstract] [Full Text] [Related]
38. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. Rousseau C, Pettersson F, Couture MC, Paquin A, Galipeau J, Mader S, Miller WH. J Steroid Biochem Mol Biol; 2003 Jul 16; 86(1):1-14. PubMed ID: 12943740 [Abstract] [Full Text] [Related]
39. The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. Yamamoto Y, Wada O, Suzawa M, Yogiashi Y, Yano T, Kato S, Yanagisawa J. J Biol Chem; 2001 Nov 16; 276(46):42684-91. PubMed ID: 11553641 [Abstract] [Full Text] [Related]
40. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. Proc Natl Acad Sci U S A; 1996 Sep 17; 93(19):10069-73. PubMed ID: 8816752 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]